AACR

Prasad S. Adusumilli, Memorial Sloan Kettering Cancer Center, New York, New York
Nilofer S. Azad, Johns Hopkins University, Baltimore, Maryland
John C. Byrd, The Ohio State University Wexner Medical Center, Columbus, Ohio
Jayesh Desai, Peter MacCallum Cancer Centre, Melbourne, Australia
Maximilian Diehn, Stanford University, Stanford, California
Jeffrey A. Engelman, Novartis, Cambridge, Massachusetts
Susan M. Galbraith, AstraZeneca, Cambridge, England
Benjamin Haibe-Kains, UHN Princess Margaret Cancer Centre, Toronto, ON, Canada
Jonathan Hirsch, Syapse, Palo Alto, California
David M. Hyman, Loxo Oncology at Lilly, Stamford, Connecticut
Nada Jabado, McGill University, Montréal, QC, Canada
Pasi A. Jänne, Dana-Farber Cancer Institute, Boston, Massachusetts
Marina Y. Konopleva, The University of Texas MD Anderson Cancer Center, Houston, Texas
Brigette B. Ma, Chinese University of Hong Kong, Hong Kong
Zoran Rankovic, St. Jude Children’s Research Hospital, Memphis, Tennessee
Antoni Ribas, University of California Los Angeles (UCLA), Jonsson Comprehensive Cancer Center (JCCC), Los Angeles, California
William R. Sellers, Broad Institute, Cambridge, Massachusetts
Alexandra Snyder Charen, Merck & Co., Inc., Rahway, New Jersey

NCI

Alice P. Chen, National Cancer Institute, Bethesda, Maryland
Peter L. Choyke, National Cancer Institute, Bethesda, Maryland
James H. Doroshow, National Cancer Institute, Bethesda, Maryland
Marc S. Ernstoff, National Cancer Institute, Bethesda, Maryland
William D. Figg, National Cancer Institute, Bethesda, Maryland
Lyndsay N. Harris, National Cancer Institute, Rockville, Maryland
Toby T. Hecht, National Cancer Institute, Rockville, Maryland
S. Percy Ivy, National Cancer Institute, Bethesda, Maryland
Stanley Lipkowitz, National Cancer Institute, Bethesda, Maryland
Jeffrey A. Moscow, National Cancer Institute, Bethesda, Maryland
Barry R. O’Keefe, National Cancer Institute, Frederick, Maryland
Eytan Ruppin, National Cancer Institute, Bethesda, Maryland
Beverly A. Teicher, National Cancer Institute, Bethesda, Maryland
Carole J. Thiele, National Cancer Institute, Bethesda, Maryland
John J. Wright, National Cancer Institute, Rockville, Maryland

EORTC

Dereck D. Amakye, Bayer HealthCare, Leverkusen, Germany
Ahmad Awada, Institut Jules Bordet, Brussels, Belgium
Jan Bussink, Radboud University Medical Center, Nijmegen, Netherlands
George Coukos, UNIL University of Lausanne, Lausanne, Switzerland
Kapil Dhingra, KAPital Consulting LLC, Sparta, New Jersey
Elena Garralda, Vall D’Hebron Institute of Oncology, Barcelona, Spain
Ioannis Gounaris, Merck Healthcare KGaA, Cambridge, England
Viktor Grünwald, Hannover Medical School, Hannover, Germany
Egesta Lopci, Istituto Clinico Humanitas, Milan, Italy
Christophe Massard, Princess Máxima Center for Pediatric Oncology, Villejuif, France
Eric Raymond, Paris Saint-Joseph Hospital, Paris, France
Jean-Charles Soria, Institut Gustave Roussy, Villejuif, France
Stefan N. Symeonides, University of Edinburgh, Edinburgh, Scotland
Jaap Verweij, Cancer Drug Development Forum, Brussels, Belgium
Mike Waring, Northern Institute for Cancer Research, Newcastle upon Tyne, England